MyDrHank review
Desk Score
Every price MyDrHank advertises is the cheapest rung of a four-term ladder — its own code renders the annual-prepay rate as “From $X/mo”, so the month-to-month cost of $349 tirzepatide and $259 semaglutide appears nowhere in the marketing.
At a glance
- Semaglutide
- $259/mo
- Tirzepatide
- $349/mo
- State access
- Check eligibility
- Brand-name access
- Not established in this review
In this review
Is MyDrHank legit?
Only what MyDrHank publishes and what we could check ourselves. See the methodology.
- Certification
- Third-party certification has not been established in this review.
- Where it ships
- 44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia), as published on the site.
- Published price
- MyDrHank publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does MyDrHank cost?" below.
- What it sells
- An oral option is listed; confirm the formulation. Confirm the exact medication and route before starting intake.
- Licensing & trust
- 76/100 on the scored dimension of that name — one of the six in our published methodology.
A month-to-month rate is published in the dated information reviewed. Confirm treatment-specific state access and the full purchase terms before choosing a provider.
What does MyDrHank cost?
Each figure keeps its billing conditions. Our ranked semaglutide providers show how other programs bill for the same medication.
$259/mo month-to-month (compounded injectable; oral $249/mo; the injection's advertised $178/mo is a $2,140 annual prepay, and the $171/mo on its sign-up pages is the oral tablet's $2,057 annual prepay)
That is a flat month-to-month rate: $259 a month, with no plan term attached to the figure.
Median semaglutide figure across this site: $190 a month, of 164 providers with a published month-to-month price and a check date. MyDrHank's $259 a month sits $69 above it.
$349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay)
That is a flat month-to-month rate: $349 a month, with no plan term attached to the figure.
Median tirzepatide figure across this site: $259 a month, of 165 providers with a published month-to-month price and a check date. MyDrHank's $349 a month sits $90 above it.
How it’s billed
Every price MyDrHank advertises is the cheapest rung of a four-term ladder, and the month-to-month rate is displayed nowhere in the marketing. That is not an inference. The site's own code builds its price component by taking the minimum per-month figure across the term ladder and printing it as "From" plus that figure plus "/mo" — so the advertised number is the annual-prepay rate by construction, on every product, with nothing on the card saying so.
Use the MyDrHank vs CoreAge Rx comparison to check which costs apply to the same medication and billing interval. To see how other programs publish these terms, read our bmiMD review and our MEDGm review; we may earn a commission from both.
The catalog behind it is complete and we read it directly. Compounded tirzepatide: $349 a month billed monthly, $890 a quarter which is $297 a month, $1,602 for six months which is $267 a month, and $2,883 for a year which is $240 a month. Injectable compounded semaglutide: $259 a month billed monthly, $660 a quarter or $220 a month, $1,189 for six months or $198 a month, and $2,140 for a year or $178 a month. Oral semaglutide: $249 a month billed monthly, down to $2,057 for a year or $171 a month. Those figures are identical to what we read in August, so the ladder is stable even though the headline never shows the top of it. The product pages themselves print only the bottom rung: "From $178/mo" on the semaglutide injection, "From $240/mo" on tirzepatide and "From $171/mo" on the oral tablet.
The main sign-up page leads with "Start for just $171/mo" and shows "STARTING AT $171/MO" and "STARTING AT $200/MO" on its cards. The first requires $2,057 paid up front for a year, and it belongs to the oral product rather than to the injection the card sits above; the semaglutide injection's own yearly rung is $178 a month. The second is worse: the footnote says "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide," and no tirzepatide plan is priced at $200 a month at any term — the four real figures are $349, $297, $267 and $240 a month. The FAQ compounds it by calling the prepay figure a plan with "no contract." A newer sign-up page adds a first-month offer on top: "$99 first month" and then $171/mo or $200/mo, with a footnote saying the $99 first-month pricing is available only on 3-month plans or longer.
One more oddity sits in the catalog itself. The rapid-dissolve oral GLP-1 lists a monthly total of $399 against a per-month figure of $329, and a quarterly per-month figure of $339 — so its "monthly" rate is internally inconsistent and its quarterly rung is dearer per month than its monthly one. Whichever of those is a typing error, it is being served to shoppers.
What you're buying
MyDrHank runs a wide catalog — weight loss, longevity, peptides and NAD+, sexual health, hair growth — and the weight-loss line is unusually complete: a compounded semaglutide injection, a compounded tirzepatide injection, an oral semaglutide tablet, a variant of that tablet combined with a low dose of ondansetron aimed at the nausea most people meet during titration, and a rapid-dissolve oral GLP-1. A real oral option within a few dollars of the injection, and an anti-nausea formulation on the menu at all, is a genuine point of difference.
The injection now comes with a formulation choice the product page presents up front: semaglutide with B-12, or semaglutide with glycine. MyDrHank explains the B-12 rationale at length. What it does not do is name anything else. There is no named pharmacy, no named prescriber and no named medical director — the product page says only that the medication is "compounded in an FDA-registered U.S. pharmacy" and ships temperature-controlled. Earlier research on this seller recorded three specific pharmacy names; none of them could be found on the site today, so none is credited here. The terms of use say only that a current list of pharmacy partners is available upon request.
Who can order
MyDrHank publishes no served-states list on any consumer page. The exclusions we can document come from the affiliate terms rather than from anywhere a shopper would look: Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia. That is 44 states, which is wide coverage — the criticism is not the reach but that a patient in Kansas has no way to learn it from the site.
When checking alternatives to MyDrHank, ask whether the exact treatment can be prescribed and dispensed in your state before you compare plan prices.
No minimum age, body mass index rule or live-visit requirement is published either. Screened against the FDA warning-letter database, this company has no letter against it, and nothing here should imply otherwise.
How the intake works
Three steps: a five-minute questionnaire, review by a licensed U.S. provider, then shipping from an FDA-registered pharmacy with free delivery. The consultation is free and no insurance is required, so you can reach a decision without paying — better than the sellers that take the card first.
Ongoing care is described as a dedicated clinical team with regular check-ins, dose adjustments and unlimited messaging, all included. Support hours, a phone number and a named medical director are absent. A patient portal is linked in the footer. The catalog prices each product per term rather than per milligram, and the site's FAQ text says the price stays the same at every dose. Its own pricing footnote says something else: that final pricing depends on the medication, dose and treatment plan your physician prescribes. Ask which of those governs your charge before you pay.
What we'd want changed
Show the whole ladder on the card, or show the monthly rung. The mechanism here is not a rounding error or a stale page; it is a function that deliberately prints the cheapest term as the headline. A shopper comparing "From $171/mo" against a rival's plain monthly rate is comparing a year paid in advance against a month, and the full ladder exists in the site's own catalog data without being shown on the product page — so the honest number is there, just not where a shopper can read it.
Then delete the $200 a month figure. An advertised price that is purchasable at no term is the sort of thing that turns a pricing complaint into a credibility problem, and it has survived from August into November. Fix the rapid-dissolve tablet's monthly total while you are in there, and publish the six excluded states where patients can read them.
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
What we like
- A genuine month-to-month option exists on every line — $349/mo tirzepatide, $259/mo injectable semaglutide, $249/mo oral — so nothing forces a commitment on a reader who reads the ladder
- Priced per product and per term rather than per milligram in its own catalog, and its FAQ text says the price stays the same at every dose
- A real oral semaglutide alongside the injection and within $10/mo of it, plus an ondansetron-combined tablet aimed at nausea during titration
- Free consultation, free shipping and no insurance required
- The injection now offers a formulation choice up front — semaglutide with B-12 or with glycine — chosen on the product page rather than assigned for you
- No matched FDA warning letter was found at our last documented check; this is not regulatory clearance or a safety endorsement
Where points come off
- Every advertised price is an annual-prepay minimum. The site's own code takes the cheapest rung of a four-term ladder and prints it as “From $X/mo”, so the $240/mo tirzepatide, $178/mo injectable semaglutide and $171/mo oral semaglutide it markets are what $2,883, $2,140 and $2,057 paid up front work out to per month — the month-to-month rates, $349, $259 and $249, are displayed nowhere, and the FAQ still calls the prepay figure a plan with “no contract”
- Two advertised figures match no plan — the sign-up page's pricing footnote quotes “$200/mo for compounded tirzepatide”, and MyDrHank's own four tirzepatide prices are $349, $297, $267 and $240 per month; the same page shows “$171/mo” beside the semaglutide injection, whose own product page says “From $178/mo”
- No served-states list on the consumer pages — the six excluded states (Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia) are documented in the affiliate terms, not anywhere a shopper can read them
- Compounded semaglutide and tirzepatide are not FDA-approved — not the same product as Wegovy, Ozempic or Zepbound, and there is no brand-name lane here
- No pharmacy, prescriber or medical director named — the product page says only that the medication is “compounded in an FDA-registered U.S. pharmacy”
- Its pages disagree on dose pricing — the FAQ text says the price stays the same at every dose, while the pricing footnote says final pricing depends on the medication, dose and treatment plan prescribed
Bottom line
MyDrHank has the broadest weight-loss menu we cover — injection, oral, and an oral built around nausea — with a catalog that carries no dose surcharge, a free consultation and a clean regulatory record. The real month-to-month costs are $259 a month for the semaglutide injection, $349 a month for tirzepatide and $249 a month for the oral, which places it among the dearer compounded desks rather than among the cheap ones. If you will genuinely prepay a year, $178 or $240 a month is competitive. If you will not, ignore every price on the front of this site and read the ladder.
Best for a patient who wants an oral GLP-1 or a nausea-focused formulation and will prepay a year to get the advertised rate. At month-to-month prices, $259 and $349 a month are well above the market — do the arithmetic before you start.
MyDrHank ranks #125 of 545 providers scored; our CoreAge Rx review covers the provider ranked #1.
Related reviews
- #141Nova74/100 · C
- #142SexyMD74/100 · C
- #143Edessa74/100 · C
- #144Oak71/100 · C
- #145Care Clinics73/100 · C
- #146Ozari Health73/100 · C
Everyone else here (18)
- #126 Care Bare Rx75
- #127 Bionomy Health75
- #128 Jyra Health75
- #129 PlexusDx75
- #130 AHBARx75
- #131 Better U Care74
- #132 GoodRx74
- #133 Loop Health74
- #134 NovoCare Pharmacy74
- #135 TeleClinic74
- #136 Queen RX74
- #137 Knownwell74
- #138 Lemonaid Health74
- #139 Tell Her Doc74
- #140 Somira Health74
- #147 PlushCare73
- #148 Calibrate Health73
- #149 Invyncible73
Pricing and verification reflect MyDrHank's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.
MyDrHank